Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact


Life Science Knowledge Now.

Xtalks Vitals is your source for in-depth blog articles, breaking news, engaging videos and interactive polls and quizzes, all created with the life science industry in mind. Xtalks Vitals is your source for interactive content. Subscribe today!



Xtalks Vitals Blog  
Xtalks Vitals Quizzes & Polls

 Preparing for ICH-GCP E6(R2): A Former GCP Inspector Answers Your Compliance Questions
As this new rule will have an impact on all stakeholders in the clinical trials process – including study sponsors, contract research organizations (CROs), and investigator sites – it’s important that the guidelines are fully understood before GCP inspectors begin implementing them. I had a chance to speak with Gunnar Danielsson, a former GCP Inspector for the Swedish Medical Products Agency and European Medicines Agency, who now helps the industry and academia as an independent consultant.



Take Our Other Quizzes Here

 
 Xtalks Vitals News

Xtalks Vitals Videos


Magnetic Implant Could Offer Improved Control Over Drug Delivery
Researchers at the University of British Columbia (UBC) have developed Canada’s first magnetic drug implant as an alternative mode of drug delivery.

Valeant’s Plaque Psoriasis Drug Gains FDA Approval
The US Food and Drug Administration (FDA) has approved Valeant’s injectable plaque psoriasis drug, Siliq (brodalumab).

Implantable Defibrillator Could Present More Cardiac Problems for Some Patients
According to a new study published in the journal, Circulation: Cardiovascular Quality and Outcomes, patients who receive a shock from an implantable cardioverter defibrillator (ICD) could require further medical attention for cardiac issues.

Using MRI to Detect Autism Biomarkers in Infants
Using the brain imaging technique, the researchers showed 80 percent accuracy in predicting which children would be diagnosed with autism at 24 months.


 




 
Copyright © 2016-2017 Honeycomb Worldwide Inc.